Treatment-related serious adverse events and fatal adverse events with regorafenib in cancer patients: a meta-analysis of phase 3 randomized controlled trials
Article in Investigational New Drugs (September 2017)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Investigational New Drugs (September 2017)
Article in World Journal of Experimental Medicine (November 2014)
Article in Clinical Cancer Research (June 2014)